Broker Forecast - Deutsche Bank issues a broker note on Barratt Developments PLC

Deutsche Bank today initiates coverage of Barratt Developments PLC (LON:BDEV) with a hold investment rating and price target of 648p.

Broker Forecasts data provided by...

Wed, 04/09/2019 - 08:00


Mobile Streams to de-list from AIM, become a private company

Mobile entertainment content provider Mobile Streams said it would seek approval from its shareholders to cancel trading of its shares and become a private company....

Wed, 04/09/2019 - 07:58


Kainos expects results to meet market expectations amid 'solid' growth in digital services

Kainos said it expected full-year results to meet market expectations amid 'solid' digital services growth.

The company said it had delivered a 'solid' digital...

Wed, 04/09/2019 - 07:57


Secure Income REIT lifts dividend 31% as earnings improve

Secure Income REIT upped its dividend by 31% after increased rental income helped it boost its first-half earnings.

The property investor declared an interim dividend...

Wed, 04/09/2019 - 07:55


Premier African Minerals gets loan repayment extension from Regent Mercantile

Premier African Minerals said it had agreed with Regent Mercantile to extend the repayment terms of a $0.35m convertible loan note entered into in June....

Wed, 04/09/2019 - 07:49


British American Tobacco prices $3.5bn bond offering

British American Tobacco said it had priced an offering of $3.5bn bond to refinance upcoming maturities, potentially redeem some of its bonds before maturity and...

Wed, 04/09/2019 - 07:46


Watchstone losses deepen as insurance unit drags

Healthcare and insurance company Watchstone booked a deeper first-half loss after its insurance unit Ingenie faced 'difficult market conditions'.

Pre-tax losses for the six months...

Wed, 04/09/2019 - 07:46


AstraZeneca lung cancer treatment gets regulatory nod in China

AstraZeneca said its lung cancer drug received marketing approval in China as a 1st-line treatment based on results from a clinical trial.

In the Flaura...

Wed, 04/09/2019 - 07:41


Oxford Biomedica losses deepen as sales fall, R&D costs rise

Gene and cell therapy company Oxford Biomedica booked a deeper first-half loss, after sales fell and it upped spending on R&D.

Pre-tax losses for the...

Wed, 04/09/2019 - 07:39


Mporium forms commercial partnership with Click Labs

Marketing company Mporium said it had formed a commercial partnership with performance marketing agency Click Labs.

The collaboration would see Mporium deploying its technology across...

Wed, 04/09/2019 - 07:33


Pages